omniture

China Kangtai Cactus Biotech Announces Preliminary Year End 2006 Results

Net Sales Increase 110%; Net Income Grows Over 300%

HARBIN, China, Jan. 23 /Xinhua-PRNewswire/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, today reported preliminary, unaudited results for the year ended December 31, 2006. All estimated results reported are in U.S. dollars. The preliminary unaudited results indicate that net sales for the year-ended December 31, 2006 will increase to approximately $17 million, which would represent an increase of approximately 110% as compared to net sales of $8 million for the year ended December 31, 2005. The preliminary unaudited results also indicate that net income from operations for the year ended December 31, 2006 will increase to approximately $3.4 million, which would represent an increase of more than 300% over net income from operations of $795,000 for the year ended December 31, 2005. Final audited results are expected to be reported in mid-February.

Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, "Our projected revenue growth for 2006 is attributed to a growing demand for our high quality cactus-based consumer products throughout China, as well as our continuing efforts to expand our growing distribution network."

Wang concluded, "Our Company remains focused on creating more product categories and lines for distribution and enhancing our sales support as well as our inventory management systems. With 17 product patents and 15 pending approval, China Kangtai is the dominant company in the cactus-based consumer product sector."

About China Kangtai Cactus Bio-Tech Inc.

China Kangtai Cactus Bio-Tech Inc. is market-leading cactus grower and producer of cactus-related products with over 520 acres of plants and an active R&D group that holds 17 product patents and is seeking another 15 in a variety of product categories. Kangtai's high-quality products are sold throughout China through a growing distribution network that includes franchised, company-owned and third party stores, as well as store counters in supermarkets, department stores, hotels, restaurants and malls.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information about China Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Bio-tech future performance, operations and products.

This forward-looking information should be considered only in connection with "Risk Factors" in China Kangtai Cactus Bio-tech's quarterly report on Form 10-Q filed with the SEC on November 14, 2006, and its other current and periodic reports filed with the SEC. China Kangtai Cactus Bio-tech assumes no obligations to update any forward-looking statements or information set forth in this press release.

For more information, please contact:

Ren Hu

China Kangtai Cactus Bio-tech, Inc.

Tel: +1-201-887-0415

Email: Arenhu@gmail.com

Adam Friedman

Adam Friedman Associates

Tel: +1-212-981-2529 ext. 18

Email: adam@adam-friedman.com

Source: China Kangtai Cactus Biotech, Inc.
Related Stocks:
OTC:CKGT
collection